Toxicity and bioaccumulation of cadmium in Chlorella.

Chlorella pyrenoidosa cultures grown at pH 7 in the presence of 0, 0.25, 0.50, and 1.00 mg of Cd/liter had doubling times of 11, 21, 22, and 35 hours, respectively, whereas similarly exposed cultures grown at pH 8 had doubling times of 11, 16, 17, and 25 hours, respectively. C. pyrenoidosa is capable of concentrating cadmium, and the amount accumulated is directly proportional to the concentration of metal present initially and is dependent upon the pH of the medium. No accumulation occurs in the dark, at 4°C, or in dead cells. Cadmium accumulation is not affected by the concentration of calcium, magnesium, molybdenum, copper, zinc, or cobalt in the growth medium, whereas a level of manganese equal to 0.20 mg/liter completely blocks cadmium accumulation; iron may also play a role in regulating cadmium accumulation. Cells which had accumulated cadmium could still fix atmospheric CO₂, albeit at reduced rates; O₂ evolution was also inhibited, but to a lesser extent. The ability of C. pyrenoidosa to accumulate large concentrations of cadmium before showing adverse effects may be related to the presence of cadmium-sequestering agent(s) within the cell. The concentration of cadmium by C. pyrenoidosa could pose a hazard to the freshwater food chain.     

A COMPARISON OF THE OUTCOME OF DAY-CARE AND INPATIENT TREATMENT OF PAEDIATRIC SURGICAL CASES

The outcome of day-care versus inpatient surgery for two equivalent groups of children is examined. Ratings were made of medical outcome, behaviour change in the children at 1 week and 3 mths post-discharge from a pre-admission criterion, convenience and subjective anxiety for parents, and relative costs of the two procedures. Results showed trends in favour of the day-care procedure. Argument is made that day-care should be the preferred option for minor surgery in young children.     

Association between anti-tumour necrosis factor therapy and risk of ischaemic stroke in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registers-Rheumatoid Arthritis (BSRBR-RA)

BackgroundPeople with rheumatoid arthritis are at increased risk of cardiovascular morbidity and mortality, including stroke (cerebrovascular accident [CVA]). Anti-tumour necrosis factor (anti-TNF) therapy may influence the risk of CVA by reducing inflammation. The aim of the analysis was to study the association of anti-TNF therapy with risk of ischaemic CVA in rheumatoid arthritis.MethodsThe British Society for Rheumatology Biologics Registers-Rheumatoid Arthritis (BSRBR-RA) is an ongoing national prospective observational cohort study. Patients with rheumatoid arthritis recently started on anti-TNF therapy and a biologic-naive comparator group treated only with non-biologic disease modifying anti-rheumatic drugs (nbDMARDs) were recruited to the BSRBR-RA from 2001 to 2008. Patients were followed by physician and patient questionnaires and also linked to the national death register. Incident CVAs were identified from all three sources of follow-up. CVAs were validated against WHO criteria for CVA and further classified as ischaemic CVA using CT brain reports or if ischaemic CVA was reported as the underlying cause of death from death certificates according to International Classification of Diseases 10 (ICD-10) code I63. Patients with a previous CVA were excluded. Risk of ischaemic CVA was compared between the nbDMARD cohort and people ever exposed to anti-TNF using a Cox regression model. Missing baseline data were replaced by multiple imputation. Adjustment was made for confounders using propensity scores stratified by deciles.FindingsTo Oct 31, 2010, 130 verified incident ischaemic CVAs (21 in 3271 nbDMARD patients, 109 in 11 642 anti-TNF patients) had occurred during 11 973 and 61 226 person-years of observation, respectively (incidence rate 175 vs 178 per 100 000 person-years). After adjustment for confounders, there was no association between ever exposure to anti-TNF and ischaemic CVA risk (hazard ratio 0·88 [95% CI 0·46–1·71]).InterpretationExposure to anti-TNF therapy does not appear to be associated with risk of ischaemic CVA when compared with nbDMARD therapy. Further follow-up is needed to assess time-varying risk.FundingBritish Society for Rheumatology.     

Germline transformation of the diamondback moth, Plutella xylostella L., using the piggyBac transposable element

The diamondback moth, Plutella xylostella, is one of the most economically important agricultural pests. The larvae of this moth cause damage by feeding on the foliage of cruciferous vegetables such as cabbage, broccoli, cauliflower and rapeseed. Control generally comprises chemical treatment; however, the diamondback moth is renowned for rapid development of resistance to pesticides. Other methods, such as biological control, have not been able to provide adequate protection. Germline transformation of pest insects has become available in recent years as an enabling technology for new genetics‐based control methods, such as the Release of Insects carrying a Dominant Lethal (RIDL^®). In the present study, we report the first transformation of the diamondback moth, using the piggyBac transposable element, by embryo microinjection. In generating transgenic strains using four different constructs, the function of three regulatory sequences in this moth was demonstrated in driving expression of fluorescent proteins. The transformation rates achieved, 0.48–0.68%, are relatively low compared with those described in other Lepidoptera, but not prohibitive, and are likely to increase with experience. We anticipate that germline transformation of the diamondback moth will permit the development of RIDL strains for use against this pest and facilitate the wider use of this species as a model organism for basic studies.